Radiochemotheraphy-induced oral mucositis: Ectoin solution as a new Treatment.
Written by Adriana Fondevilla, Ana Serradilla, Elena Moreno-Olmedo, Kirill Matskov, María José Belmonte, Antonio Sáez, María José Acevedo, Escarlata López
Resumen
The current treatment for head and neck cancer involves radiotherapy, systemic therapy and surgery in a multidisciplinary approach. Unfortunately, cancer therapies can lead to local and systemic complications or side effects such as mucositis, which is the most common dose-dependent complication in the oral cavity and gastrointestinal tract. Mucositis can cause a considerably reduced quality of life in cancer patients already suffering from physical and psychological exhaustion. Moreover, radiotherapy interruptions due to toxicity can impact negatively in local control and survival. The main purpose of this study was to analyze patient satisfaction of Ectoin solution use in radiotherapy or radiochemotherapy-induced oral mucositis.